MCID: BLD051
MIFTS: 52

Blood Coagulation Disease

Categories: Blood diseases, Genetic diseases

Aliases & Classifications for Blood Coagulation Disease

MalaCards integrated aliases for Blood Coagulation Disease:

Name: Blood Coagulation Disease 12 15 17
Blood Coagulation Disorders 77 45 74
Postpartum Coagulation Defect with Delivery 12
Postpartum Coagulation Defect 12

Classifications:



External Ids:

Disease Ontology 12 DOID:1247
ICD9CM 36 286
MeSH 45 D001778
NCIt 51 C2902
SNOMED-CT 69 64779008
ICD10 34 D68.9 O72.3
UMLS 74 C0005779

Summaries for Blood Coagulation Disease

MalaCards based summary : Blood Coagulation Disease, also known as blood coagulation disorders, is related to inherited blood coagulation disease and antithrombin iii deficiency. An important gene associated with Blood Coagulation Disease is VWF (Von Willebrand Factor), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Collagen chain trimerization. The drugs Warfarin and Tranexamic Acid have been mentioned in the context of this disorder. Affiliated tissues include bone, t cells and bone marrow, and related phenotypes are no effect and hematopoietic system

Wikipedia : 77 Coagulopathy (also called a bleeding disorder) is a condition in which the blood’s ability to coagulate... more...

Related Diseases for Blood Coagulation Disease

Diseases in the Blood Coagulation Disease family:

Inherited Blood Coagulation Disease

Diseases related to Blood Coagulation Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 171, show less)
# Related Disease Score Top Affiliating Genes
1 inherited blood coagulation disease 33.0 F2 F3 F7 F8 F9 GP1BA
2 antithrombin iii deficiency 32.0 F2 MTHFR SERPINC1
3 bleeding disorder, platelet-type, 16 32.0 ITGA2B ITGB3
4 pseudo-von willebrand disease 32.0 GP1BA GP9 VWF
5 acquired von willebrand syndrome 32.0 F8 F9 GP1BA VWF
6 prothrombin deficiency, congenital 31.9 F2 SERPINC1
7 factor vii deficiency 31.8 F2 F3 F7 F8 F9
8 hemophilia b 31.7 F2 F3 F7 F8 F9 SERPINC1
9 factor v deficiency 31.7 F2 F3 F7 F8 F9 VWF
10 bernard-soulier syndrome 31.3 F2 F8 GP1BA GP9 ITGA2B ITGB3
11 glanzmann thrombasthenia 31.1 F2 F3 F8 F9 GP1BA GP9
12 thrombosis 28.8 ADAMTS13 F2 F3 F7 F8 F9
13 gray platelet syndrome 11.0
14 bleeding disorder, platelet-type, 17 11.0
15 scott syndrome 11.0
16 quebec platelet disorder 11.0
17 bleeding disorder, platelet-type, 12 11.0
18 platelet glycoprotein iv deficiency 11.0
19 bleeding disorder, platelet-type, 8 11.0
20 bleeding disorder, platelet-type, 14 11.0
21 bleeding disorder, platelet-type, 9 11.0
22 bleeding disorder, platelet-type, 11 11.0
23 bleeding disorder, platelet-type, 15 11.0
24 bleeding disorder, platelet-type, 18 11.0
25 bleeding disorder, platelet-type, 19 11.0
26 bleeding disorder, platelet-type, 20 11.0
27 factor xiii deficiency 11.0
28 factor v and factor viii, combined deficiency of, 1 10.9
29 factor v and factor viii, combined deficiency of, 2 10.9
30 fainting 10.5 F8 VWF
31 unilateral absence of a pulmonary artery 10.5 THBD VWF
32 cerebral falx meningioma 10.5 F2 F3
33 intestinal impaction 10.5 F2 F3 SERPINC1
34 giant hemangioma 10.5 F2 F3 SERPINC1
35 bombay phenotype 10.5 ADAMTS13 VWF
36 sagittal sinus thrombosis 10.5 F2 F3 SERPINC1
37 cerebral arteritis 10.5 F8 VWF
38 blue toe syndrome 10.5 F2 F3 SERPINC1
39 heparin-induced thrombocytopenia 10.4 F3 SERPINC1
40 brachydactyly, type d 10.4 F2 F8 VWF
41 factor viii deficiency 10.4 F2 F8 VWF
42 acquired hemophilia 10.4 F3 F8 F9
43 purpura fulminans 10.4 F2 F3 SERPINC1
44 acquired hemophilia a 10.4 F3 F8 F9
45 peripheral vertigo 10.4 F2 F3 SERPINC1
46 prothrombin deficiency 10.4 F2 F3 F7
47 hypersplenism 10.4 F2 SERPINC1 THPO
48 post-thrombotic syndrome 10.4 F2 F8 SERPINC1
49 cerebral sinovenous thrombosis 10.4 F2 F3
50 cardiac tamponade 10.4 F2 F8 F9
51 splenic disease 10.4 F2 F3 THPO
52 factor xii deficiency 10.4 F3 F9 SERPINC1
53 thrombocytopenia 3 10.4 MPL THPO
54 intermittent claudication 10.4 F2 SERPINC1 VWF
55 lateral sinus thrombosis 10.4 F9 MTHFR
56 anterior cranial fossa meningioma 10.4 F2 F3 F7
57 thrombocythemia 1 10.4 MPL THPO
58 spinal cord infarction 10.4 F2 MTHFR SERPINC1
59 alpha-2-plasmin inhibitor deficiency 10.4 F2 SERPINC1
60 platelet aggregation, spontaneous 10.4 PF4 SERPINC1 VWF
61 korean hemorrhagic fever 10.4 F2 F3 SERPINC1 VWF
62 spotted fever 10.4 F2 THBD VWF
63 intracranial embolism 10.4 F2 SERPINC1
64 sticky platelet syndrome 10.4 ITGB3 SERPINC1
65 dysfibrinogenemia 10.4 F2 SERPINC1 THBD
66 retinal vascular occlusion 10.4 F2 MTHFR SERPINC1
67 catastrophic antiphospholipid syndrome 10.4 ADAMTS13 F3 MTHFR
68 active peptic ulcer disease 10.4 F2 VWF
69 malignant skin fibrous histiocytoma 10.4 F7 F9 ITGA2B
70 afibrinogenemia, congenital 10.4 F2 F3 SERPINC1 VWF
71 mesenteric vascular occlusion 10.4 F2 F7 MTHFR
72 fournier gangrene 10.4 F2 F3 F8 SERPINC1
73 portal hypertension 10.4 F2 THPO VWF
74 von willebrand disease, type 1 10.4 F2 F3 F8 VWF
75 central retinal vein occlusion 10.4 F2 MTHFR SERPINC1
76 malignant dermis tumor 10.4 F7 F9 ITGA2B
77 retinal vein occlusion 10.4 F2 MTHFR SERPINC1
78 intermediate coronary syndrome 10.4 F3 ITGA2B SERPINC1 VWF
79 dyskeratosis congenita, autosomal dominant 6 10.4 MPL THPO
80 fetal and neonatal alloimmune thrombocytopenia 10.4 GP1BA ITGA2B ITGB3
81 sudden sensorineural hearing loss 10.4 F2 ITGB3 MTHFR
82 hemolytic uremic syndrome, atypical 1 10.4 ADAMTS13 THBD VWF
83 afibrinogenemia 10.4 F2 F3 F8 VWF
84 hemarthrosis 10.4 F7 F8 F9 VWF
85 autosomal dominant macrothrombocytopenia 10.4 GP1BA ITGA2B ITGB3
86 osteonecrosis 10.4 F2 MTHFR SERPINC1
87 aspirin allergy 10.3 ITGA2B SERPINC1 WDTC1
88 homocysteinemia 10.3 F2 MTHFR SERPINC1
89 placenta disease 10.3 F3 MTHFR SERPINC1
90 thrombotic thrombocytopenic purpura 10.3 ADAMTS13 F3 THBD VWF
91 infective endocarditis 10.3 F2 GP1BA ITGB3
92 retinal artery occlusion 10.3 F2 F8 MTHFR SERPINC1
93 hepatic veno-occlusive disease 10.3 F3 SERPINC1 THBD THPO
94 hemolytic-uremic syndrome 10.3 ADAMTS13 F3 THBD VWF
95 leech infestation 10.3 F2 F3 PF4 SERPINC1
96 thrombocytopenia-absent radius syndrome 10.3 GP1BA MPL THPO
97 hepatic infarction 10.3 F2 F3 MTHFR SERPINC1
98 blood protein disease 10.3 F2 F3 MTHFR SERPINC1
99 pulmonary artery disease 10.3 F2 F3 MTHFR SERPINC1
100 varicose veins 10.3 F2 MTHFR SERPINC1 VWF
101 protein s deficiency 10.3 F2 F3 MTHFR SERPINC1
102 livedoid vasculitis 10.3 F2 F8 MTHFR SERPINC1
103 patent foramen ovale 10.3 F2 MTHFR SERPINC1
104 thrombophlebitis 10.3 F2 F8 MTHFR SERPINC1
105 intracranial hypertension 10.3 F2 F3 MTHFR SERPINC1
106 acute myocardial infarction 10.3 F3 ITGA2B SERPINC1 VWF
107 portal vein thrombosis 10.3 F2 F7 MTHFR SERPINC1
108 qualitative platelet defect 10.3 F2 F3 VWF WDTC1
109 eclampsia 10.3 F2 MTHFR SERPINC1 THBD
110 liver cirrhosis 10.3 F2 F3 SERPINC1 THPO
111 grange syndrome 10.3 F3 MTHFR THBD VWF
112 placental abruption 10.3 F2 MTHFR SERPINC1 THBD
113 nonarteritic anterior ischemic optic neuropathy 10.3 F2 GP1BA MTHFR SERPINC1
114 megakaryocytic leukemia 10.3 ITGA2B PF4 THPO VWF
115 alcohol-related birth defect 10.3 F2 F3 F8 WDTC1
116 peripheral vascular disease 10.3 F2 F3 SERPINC1 THBD VWF
117 hemophilia a 10.3 F3 F7 F8 F9 VWF
118 factor xi deficiency 10.3 F2 F3 F9 SERPINC1 THBD
119 thrombocytosis 10.3 F2 F3 MPL SERPINC1 THPO
120 femoral neuropathy 10.3 F2 F3
121 hepatic vascular disease 10.3 F2 F3 MTHFR SERPINC1 VWF
122 ischemic neuropathy 10.3 F2 MTHFR
123 arteritic anterior ischemic optic neuropathy 10.3 F2 GP1BA ITGB3 MTHFR
124 coronary thrombosis 10.2 F3 GP1BA ITGB3 SERPINC1 VWF
125 vein disease 10.2 F2 F3 F8 MTHFR SERPINC1
126 budd-chiari syndrome 10.2 F2 F3 F7 MTHFR SERPINC1
127 marantic endocarditis 10.2 F2 F3 MTHFR SERPINC1 THBD
128 protein c deficiency 10.2 F2 F9 MTHFR SERPINC1 THBD
129 factor x deficiency 10.2 F2 F3 F7 F9 SERPINC1 VWF
130 cerebrovascular disease 10.2 F2 F7 ITGA2B MTHFR VWF
131 arteries, anomalies of 10.2 F3 ITGA2B SERPINC1 VWF WDTC1
132 hemophilia 10.2 F2 F3 F7 F8 F9 VWF
133 ischemic optic neuropathy 10.2 F2 GP1BA ITGB3 MTHFR SERPINC1
134 von willebrand disease, type 3 10.2 ATAT1 F3 F8 GP1BA VWF
135 coronary artery anomaly 10.2 F2 F7 PF4
136 thrombocytopenic purpura, autoimmune 10.2 GP1BA ITGA2B ITGB3 MPL THPO
137 thrombocytopenia due to platelet alloimmunization 10.2 GP9 ITGA2B ITGB3 MPL THPO
138 pulmonary embolism 10.2 F2 F3 F9 MTHFR SERPINC1 VWF
139 branch retinal artery occlusion 10.2 F2 F3 MTHFR SERPINC1 WDTC1
140 cold urticaria 10.2 PF4 SERPINC1
141 intracranial thrombosis 10.1 F3 F8 ITGA2B MTHFR SERPINC1 VWF
142 pre-eclampsia 10.1 F2 F3 MTHFR SERPINC1 THBD VWF
143 polycythemia vera 10.1 ITGB3 MPL PF4 THBD THPO
144 von willebrand's disease 10.1 ADAMTS13 F2 F3 F8 F9 GP1BA
145 disseminated intravascular coagulation 10.1 ADAMTS13 F2 F3 F7 F9 SERPINC1
146 malaria 10.1 ADAMTS13 F3 PF4 SERPINC1 THBD VWF
147 antiphospholipid syndrome 10.1 ADAMTS13 F2 F3 MTHFR SERPINC1 THBD
148 bone marrow cancer 10.1 ITGB3 MPL PF4 THBD THPO VWF
149 hellp syndrome 10.1 ADAMTS13 F2 F3 MTHFR SERPINC1 THBD
150 cryptogenic cirrhosis 10.0 F2 MTHFR
151 thrombophilia due to thrombin defect 10.0 F2 F3 F8 MTHFR SERPINC1 THBD
152 primary thrombocytopenia 10.0 ADAMTS13 GP1BA ITGA2B ITGB3 MPL THPO
153 autoimmune disease of blood 10.0 ADAMTS13 GP1BA ITGA2B ITGB3 MPL THPO
154 thrombophilia 9.9 F2 F3 F8 F9 MTHFR SERPINC1
155 thrombasthenia 9.9 F2 F3 GP1BA GP9 ITGA2B ITGB3
156 vascular disease 9.9 F2 F3 GP1BA ITGB3 MTHFR SERPINC1
157 heart disease 9.9 F2 F3 F7 F8 MTHFR PF4
158 thrombophilia due to activated protein c resistance 9.8 F2 F3 F8 F9 MTHFR PF4
159 stroke, ischemic 9.8 ADAMTS13 F2 F3 F7 MTHFR PF4
160 von willebrand disease, type 2 9.8 ADAMTS13 ATAT1 F3 F7 F8 GP1BA
161 purpura 9.8 ADAMTS13 F2 F3 ITGA2B ITGB3 MPL
162 leptospirosis 9.8
163 arteriosclerosis 9.8
164 arteriosclerosis obliterans 9.8
165 vasculitis 9.8
166 cytomegalovirus infection 9.8
167 thrombocytopenia 9.7 ADAMTS13 F3 GP1BA GP9 ITGA2B ITGB3
168 essential thrombocythemia 9.6 F2 F3 GP1BA ITGA2B ITGB3 MPL
169 myocardial infarction 9.3 ADAMTS13 F2 F3 F7 F8 GP1BA
170 hemorrhagic disease 9.3 ADAMTS13 F2 F3 F7 F8 F9
171 blood platelet disease 9.2 ADAMTS13 F2 F3 F8 GP1BA GP9

Graphical network of the top 20 diseases related to Blood Coagulation Disease:



Diseases related to Blood Coagulation Disease

Symptoms & Phenotypes for Blood Coagulation Disease

GenomeRNAi Phenotypes related to Blood Coagulation Disease according to GeneCards Suite gene sharing:

27 (showing 1, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 no effect GR00402-S-1 9.92 ADAMTS13 ATAT1 F2 F3 F7 F8

MGI Mouse Phenotypes related to Blood Coagulation Disease:

47 (showing 6, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.16 ADAMTS13 ATAT1 F2 F3 F8 F9
2 homeostasis/metabolism MP:0005376 10.09 ADAMTS13 F2 F3 F7 F8 F9
3 cardiovascular system MP:0005385 10.02 F2 F3 F7 F9 ITGA2B ITGB3
4 embryo MP:0005380 9.92 F2 F3 F9 ITGA2B ITGB3 MPL
5 immune system MP:0005387 9.73 ADAMTS13 F2 F3 F8 F9 ITGA2B
6 mortality/aging MP:0010768 9.47 ADAMTS13 ATAT1 F2 F3 F7 F8

Drugs & Therapeutics for Blood Coagulation Disease

Drugs for Blood Coagulation Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 1018, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Warfarin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 81-81-2 54678486 6691
2
Tranexamic Acid Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 1197-18-8 5526
3
Nadroparin Approved, Investigational Phase 4,Not Applicable
4
Dalteparin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 9005-49-6
5
Heparin Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 9005-49-6 46507594 772
6
Resveratrol Approved, Experimental, Investigational Phase 4,Phase 2 501-36-0 445154
7
Indomethacin Approved, Investigational Phase 4,Phase 3 53-86-1 3715
8
Sodium Citrate Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 68-04-2
9
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 1177-87-3
10
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 50-02-2 5743
11
Melphalan Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 148-82-3 460612 4053
12
Bortezomib Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 179324-69-7 387447 93860
13
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 53-03-2 5865
14
Epirubicin Approved Phase 4,Phase 3,Phase 2 56420-45-2 41867
15
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-18-0, 6055-19-2 2907
16
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 23214-92-8 31703
17
Zoledronic Acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 118072-93-8 68740
18
Anti-inhibitor coagulant complex Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
19
Thrombin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
20
Remifentanil Approved Phase 4,Not Applicable 132875-61-7 60815
21
tannic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1401-55-4
22
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1994-09-7, 94-09-7 2337
23
Zinc Approved, Investigational Phase 4,Phase 2,Phase 1 7440-66-6 32051
24
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-78-2 2244
25
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 104987-11-3 6473866 445643 439492
26
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 302-25-0
27
Methylprednisolone hemisuccinate Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 2921-57-5
28
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 50-24-8 5755
29
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 22916-47-8 4189
30
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 83-43-2 6741
31
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 174722-31-7 10201696
32
Clarithromycin Approved Phase 4,Phase 2,Phase 3,Phase 1 81103-11-9 84029
33
Amoxicillin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 26787-78-0 33613
34
Dexlansoprazole Approved, Investigational Phase 4 138530-94-6, 103577-45-3 9578005
35
Lansoprazole Approved, Investigational Phase 4 103577-45-3 3883
36
Azathioprine Approved Phase 4,Phase 3,Phase 2,Not Applicable 446-86-6 2265
37
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2068-78-2, 57-22-7 5978
38
Lenograstim Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 135968-09-1
39
Lenalidomide Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 191732-72-6 216326
40
Enoxaparin Approved Phase 4,Phase 2,Phase 3,Not Applicable 9005-49-6 772
41
Sargramostim Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 123774-72-1, 83869-56-1
42
Apixaban Approved Phase 4,Phase 3,Phase 2,Not Applicable 503612-47-3 10182969
43
Atorvastatin Approved Phase 4,Phase 2,Phase 1 134523-00-5 60823
44
Ixazomib Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 1072833-77-2
45
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 33419-42-0 36462
46
Cytarabine Approved, Experimental, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 147-94-4, 65-46-3 6253
47
Bevacizumab Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 216974-75-3
48
Iron Approved, Experimental Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7439-89-6, 15438-31-0 27284 23925
49 Daratumumab Approved Phase 4,Phase 2,Phase 3,Phase 1 945721-28-8
50
Phenindione Approved, Investigational Phase 4 83-12-5 4760
51 Menaquinone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1182-68-9
52
Phylloquinone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 84-80-0
53 fluindione Approved, Investigational Phase 4 957-56-2
54
Acenocoumarol Approved, Investigational Phase 4,Not Applicable 152-72-7 54676537 9052
55
Rosiglitazone Approved, Investigational Phase 4 122320-73-4 77999
56
Hydrocortisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-23-7 5754
57
Hydrocortisone acetate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-03-3
58
Progesterone Approved, Vet_approved Phase 4,Not Applicable 57-83-0 5994
59
Bivalirudin Approved, Investigational Phase 4 128270-60-0 16129704
60
Chlorhexidine Approved, Vet_approved Phase 4 55-56-1 2713 9552079
61
Dexmedetomidine Approved, Vet_approved Phase 4 113775-47-6 5311068 68602
62
Insulin glargine Approved Phase 4 160337-95-1
63
Metformin Approved Phase 4,Phase 2,Phase 1 657-24-9 14219 4091
64
Insulin Lispro Approved Phase 4 133107-64-9
65
Cilostazol Approved, Investigational Phase 4 73963-72-1 2754
66
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 124-94-7 31307
67
Ropivacaine Approved Phase 4,Phase 2,Phase 3,Not Applicable 84057-95-4 175805 71273
68
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 9004-61-9 53477741
69
Ribavirin Approved Phase 4,Phase 2,Phase 1,Not Applicable 36791-04-5 37542
70
Peginterferon alfa-2a Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 198153-51-4 5360545
71
Zalcitabine Approved, Investigational Phase 4 7481-89-2 24066
72
Stavudine Approved, Investigational Phase 4 3056-17-5 18283
73
Zidovudine Approved Phase 4,Phase 1,Not Applicable 30516-87-1 35370
74
Indinavir Approved Phase 4 150378-17-9 5362440
75
Didanosine Approved Phase 4 69655-05-6 50599